Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells $84,245.20 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the sale, the chief financial officer now directly owns 140,948 shares in the company, valued at approximately $479,223.20. The trade was a 14.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Alexis Desieno also recently made the following trade(s):

• On Friday, January 3rd, Alexis Desieno sold 8,854 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total value of $32,494.18.

Cardlytics Stock Performance

Shares of CDLX opened at $2.96 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The business’s 50 day moving average price is $3.44 and its 200-day moving average price is $3.72. Cardlytics, Inc. has a 52 week low of $2.76 and a 52 week high of $20.52. The stock has a market cap of $150.43 million, a P/E ratio of -0.48 and a beta of 1.54.

Institutional Trading of Cardlytics

Hedge funds have recently made changes to their positions in the stock. Atom Investors LP bought a new stake in shares of Cardlytics in the 3rd quarter worth approximately $33,000. Tallon Kerry Patrick purchased a new position in Cardlytics in the 4th quarter worth approximately $37,000. ProShare Advisors LLC purchased a new position in Cardlytics in the 4th quarter worth approximately $43,000. SG Americas Securities LLC purchased a new position in Cardlytics in the 3rd quarter worth approximately $45,000. Finally, Intech Investment Management LLC purchased a new position in Cardlytics in the 3rd quarter worth approximately $47,000. 68.10% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CDLX has been the topic of several research reports. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $6.92.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.